These findings corroborate with the adverse impact of high SOCS3 expression on tumor progression in SOCS1-low HCC, as seen in the genetically engineered Socs1fl/flSocs3fl/flAlb-Cre mouse model (Figure 2d–h). The gene discussed is SOCS3; the disease is neoplasm.